RJFSA
GEN

Raymond James Financial Services Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,687
Closed -$6K – 3303
2020
Q4 		$6K Sell
12,687
-500
-4% -$253 ﹤0.01% 2978
2020
Q3 		$7K Buy
+13,187
New +$9.48K ﹤0.01% 2853

Other funds holding GEN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Raymond James Financial Services Advisors's GEN Position: Q1 2021 in Review

Raymond James Financial Services Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 12,687 shares — an estimated $6K sold.

Raymond James Financial Services Advisors first reported a position in GEN in Q3 2020 and held it in 2 quarters. The position peaked at $7K in Q3 2020. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Raymond James Financial Services Advisors reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 12,687 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $6K.
  • Raymond James Financial Services Advisors first reported a position in Genesis Healthcare, Inc. in Q3 2020 and held it in 2 quarters.
  • Raymond James Financial Services Advisors's Genesis Healthcare, Inc. position peaked at $7K in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2021, filed 14 May 2021.